Skip to main content
Clinical Trials/NCT06212921
NCT06212921RecruitingNot Applicable

Biomarkers In Prediction of Acute Mesenteric Ischaemia: a Prospective Multicentre Study (BIPAMI Study)

University of Tartu4 sites in 2 countries250 target enrollmentStarted: October 14, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
250
Locations
4
Primary Endpoint
Rate of correctly predicted cases of acute mesenteric ischaemia

Study Overview

Brief Summary

Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 18 years or older
  • Initial decision in favour of further diagnostics of mesenteric ischaemia

Exclusion Criteria

  • Age <18 years
  • Consent declined by patient or next of kin (delayed consent)
  • Chronic mesenteric ischaemia without an acute event
  • Immediate decision for withdrawal of further diagnostics and active treatment
  • Referral from another hospital with already established diagnosis of AMI
  • AMI diagnosed at surgery without previously having been considered

Outcomes

Primary Outcomes

Rate of correctly predicted cases of acute mesenteric ischaemia

Time Frame: 10 months

Rate of correctly predicted cases of Acute mesenteric ischaemia using different biomarkers

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Annika Reintam Blaser

Associate Professor

University of Tartu

Study Sites (4)

Loading locations...

Similar Trials